JPMorgan Upgrades Integra LifeSciences (IART) to Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as higher oil prices temper risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Reddit to join S&P 500 index on Aug. 18, shares leap
- Should you chase this mini rally in gold? Citi weighs in
Integra LifeSciences Reports Second Quarter 2015 Financial Results
July 30, 2015 6:00 AM EDTRevenue Increased 5.5% to $244.1 Million
Reported EPS of $0.15; Adjusted EPS Increased 16% to $0.79
Full Year 2015 Revenue and EPS Guidance Updated for SeaSpine Spin-off and TEI Acquisition
PLAINSBORO, N.J., July 30, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported its financial results for the second quarter ending June 30, 2015.
Highlights:
Second quarter... More